nodes	percent_of_prediction	percent_of_DWPC	metapath
Prilocaine—Tocainide—SCN10A—skin cancer	0.0345	1	CrCbGaD
Prilocaine—Paralysis—Vemurafenib—skin cancer	0.0261	0.0325	CcSEcCtD
Prilocaine—Hyperacusis—Temozolomide—skin cancer	0.0249	0.031	CcSEcCtD
Prilocaine—SCN3A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.0238	0.146	CbGpPWpGaD
Prilocaine—Trauma—Bleomycin—skin cancer	0.0231	0.0287	CcSEcCtD
Prilocaine—SCN2A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.0229	0.14	CbGpPWpGaD
Prilocaine—SCN1A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.022	0.135	CbGpPWpGaD
Prilocaine—Feeling hot—Imiquimod—skin cancer	0.0197	0.0245	CcSEcCtD
Prilocaine—Neurotoxicity—Docetaxel—skin cancer	0.0159	0.0198	CcSEcCtD
Prilocaine—SCN5A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.0155	0.095	CbGpPWpGaD
Prilocaine—Swelling—Imiquimod—skin cancer	0.0127	0.0158	CcSEcCtD
Prilocaine—Extravasation—Bleomycin—skin cancer	0.0126	0.0157	CcSEcCtD
Prilocaine—Injury—Imiquimod—skin cancer	0.0122	0.0152	CcSEcCtD
Prilocaine—Extravasation—Dactinomycin—skin cancer	0.0117	0.0146	CcSEcCtD
Prilocaine—Cardiac failure—Imiquimod—skin cancer	0.0115	0.0143	CcSEcCtD
Prilocaine—Numbness—Fluorouracil—skin cancer	0.0103	0.0128	CcSEcCtD
Prilocaine—Nervous system disorder—Vismodegib—skin cancer	0.0103	0.0128	CcSEcCtD
Prilocaine—Neuropathy peripheral—Vemurafenib—skin cancer	0.00994	0.0124	CcSEcCtD
Prilocaine—Sensory loss—Fluorouracil—skin cancer	0.00985	0.0123	CcSEcCtD
Prilocaine—Extravasation—Fluorouracil—skin cancer	0.00978	0.0122	CcSEcCtD
Prilocaine—Respiratory failure—Temozolomide—skin cancer	0.00943	0.0118	CcSEcCtD
Prilocaine—SCN3A—L1CAM interactions—SCN10A—skin cancer	0.00913	0.056	CbGpPWpGaD
Prilocaine—Dysarthria—Fluorouracil—skin cancer	0.00902	0.0112	CcSEcCtD
Prilocaine—Pain—Vismodegib—skin cancer	0.00895	0.0112	CcSEcCtD
Prilocaine—Depressed level of consciousness—Temozolomide—skin cancer	0.00894	0.0111	CcSEcCtD
Prilocaine—Disorientation—Bleomycin—skin cancer	0.00891	0.0111	CcSEcCtD
Prilocaine—SCN2A—L1CAM interactions—SCN10A—skin cancer	0.00877	0.0538	CbGpPWpGaD
Prilocaine—Neuropathy—Temozolomide—skin cancer	0.00869	0.0108	CcSEcCtD
Prilocaine—Injury—Bleomycin—skin cancer	0.00867	0.0108	CcSEcCtD
Prilocaine—Neuropathy peripheral—Imiquimod—skin cancer	0.00847	0.0106	CcSEcCtD
Prilocaine—SCN1A—L1CAM interactions—SCN10A—skin cancer	0.00846	0.0518	CbGpPWpGaD
Prilocaine—Dermatitis atopic—Docetaxel—skin cancer	0.00832	0.0104	CcSEcCtD
Prilocaine—Asthenia—Vismodegib—skin cancer	0.00751	0.00936	CcSEcCtD
Prilocaine—Euphoric mood—Fluorouracil—skin cancer	0.00733	0.00914	CcSEcCtD
Prilocaine—Tinnitus—Imiquimod—skin cancer	0.00724	0.00902	CcSEcCtD
Prilocaine—Extravasation—Docetaxel—skin cancer	0.00706	0.0088	CcSEcCtD
Prilocaine—Swelling—Fluorouracil—skin cancer	0.00702	0.00875	CcSEcCtD
Prilocaine—Arrhythmia—Imiquimod—skin cancer	0.00693	0.00864	CcSEcCtD
Prilocaine—Disorientation—Fluorouracil—skin cancer	0.00692	0.00863	CcSEcCtD
Prilocaine—Bronchospasm—Bleomycin—skin cancer	0.00678	0.00844	CcSEcCtD
Prilocaine—Diplopia—Temozolomide—skin cancer	0.00672	0.00838	CcSEcCtD
Prilocaine—Vomiting—Vismodegib—skin cancer	0.00665	0.00829	CcSEcCtD
Prilocaine—Anaphylactic shock—Vemurafenib—skin cancer	0.00647	0.00806	CcSEcCtD
Prilocaine—Cardiac failure—Fluorouracil—skin cancer	0.00635	0.00791	CcSEcCtD
Prilocaine—Nervous system disorder—Vemurafenib—skin cancer	0.00634	0.0079	CcSEcCtD
Prilocaine—Respiratory failure—Docetaxel—skin cancer	0.00627	0.00782	CcSEcCtD
Prilocaine—Nausea—Vismodegib—skin cancer	0.00622	0.00775	CcSEcCtD
Prilocaine—Osteoarthritis—Fluorouracil—skin cancer	0.00619	0.00772	CcSEcCtD
Prilocaine—Syncope—Imiquimod—skin cancer	0.00606	0.00755	CcSEcCtD
Prilocaine—Hypotension—Vemurafenib—skin cancer	0.00604	0.00753	CcSEcCtD
Prilocaine—SCN5A—L1CAM interactions—SCN10A—skin cancer	0.00595	0.0365	CbGpPWpGaD
Prilocaine—Loss of consciousness—Imiquimod—skin cancer	0.00594	0.0074	CcSEcCtD
Prilocaine—Cardiac arrest—Fluorouracil—skin cancer	0.00589	0.00734	CcSEcCtD
Prilocaine—Hypertension—Imiquimod—skin cancer	0.00583	0.00727	CcSEcCtD
Prilocaine—Neuropathy—Docetaxel—skin cancer	0.00578	0.00721	CcSEcCtD
Prilocaine—Anxiety—Imiquimod—skin cancer	0.00573	0.00714	CcSEcCtD
Prilocaine—Oedema—Imiquimod—skin cancer	0.00551	0.00687	CcSEcCtD
Prilocaine—Lightheadedness—Docetaxel—skin cancer	0.00551	0.00687	CcSEcCtD
Prilocaine—Hypoaesthesia—Bleomycin—skin cancer	0.00549	0.00684	CcSEcCtD
Prilocaine—Shock—Imiquimod—skin cancer	0.00542	0.00676	CcSEcCtD
Prilocaine—Nervous system disorder—Imiquimod—skin cancer	0.00541	0.00674	CcSEcCtD
Prilocaine—Hyperhidrosis—Imiquimod—skin cancer	0.00533	0.00664	CcSEcCtD
Prilocaine—Neuropathy peripheral—Temozolomide—skin cancer	0.00508	0.00633	CcSEcCtD
Prilocaine—Swelling—Docetaxel—skin cancer	0.00507	0.00632	CcSEcCtD
Prilocaine—Paraesthesia—Imiquimod—skin cancer	0.00495	0.00617	CcSEcCtD
Prilocaine—Somnolence—Imiquimod—skin cancer	0.0049	0.00611	CcSEcCtD
Prilocaine—Hypersensitivity—Vemurafenib—skin cancer	0.00476	0.00594	CcSEcCtD
Prilocaine—Pain—Imiquimod—skin cancer	0.00471	0.00588	CcSEcCtD
Prilocaine—Neuropathy peripheral—Fluorouracil—skin cancer	0.00468	0.00583	CcSEcCtD
Prilocaine—Asthenia—Vemurafenib—skin cancer	0.00464	0.00578	CcSEcCtD
Prilocaine—Hypoaesthesia—Temozolomide—skin cancer	0.00463	0.00577	CcSEcCtD
Prilocaine—Cardiac failure—Docetaxel—skin cancer	0.00458	0.00571	CcSEcCtD
Prilocaine—Feeling abnormal—Imiquimod—skin cancer	0.00454	0.00566	CcSEcCtD
Prilocaine—Anaemia—Bleomycin—skin cancer	0.00444	0.00553	CcSEcCtD
Prilocaine—Urticaria—Imiquimod—skin cancer	0.00438	0.00546	CcSEcCtD
Prilocaine—Tinnitus—Temozolomide—skin cancer	0.00434	0.0054	CcSEcCtD
Prilocaine—Dizziness—Vemurafenib—skin cancer	0.00428	0.00533	CcSEcCtD
Prilocaine—Hypoaesthesia—Fluorouracil—skin cancer	0.00426	0.00531	CcSEcCtD
Prilocaine—Anaemia—Dactinomycin—skin cancer	0.00414	0.00516	CcSEcCtD
Prilocaine—Vomiting—Vemurafenib—skin cancer	0.00411	0.00512	CcSEcCtD
Prilocaine—Hypersensitivity—Imiquimod—skin cancer	0.00406	0.00506	CcSEcCtD
Prilocaine—Asthenia—Imiquimod—skin cancer	0.00396	0.00493	CcSEcCtD
Prilocaine—Confusional state—Bleomycin—skin cancer	0.00395	0.00492	CcSEcCtD
Prilocaine—Oedema—Bleomycin—skin cancer	0.00392	0.00488	CcSEcCtD
Prilocaine—Anaphylactic shock—Bleomycin—skin cancer	0.00392	0.00488	CcSEcCtD
Prilocaine—Nausea—Vemurafenib—skin cancer	0.00384	0.00479	CcSEcCtD
Prilocaine—Arrhythmia—Fluorouracil—skin cancer	0.00383	0.00477	CcSEcCtD
Prilocaine—Vision blurred—Temozolomide—skin cancer	0.00382	0.00476	CcSEcCtD
Prilocaine—Bronchospasm—Docetaxel—skin cancer	0.0038	0.00474	CcSEcCtD
Prilocaine—Tremor—Temozolomide—skin cancer	0.00379	0.00473	CcSEcCtD
Prilocaine—Anaemia—Temozolomide—skin cancer	0.00374	0.00466	CcSEcCtD
Prilocaine—Hypotension—Bleomycin—skin cancer	0.00366	0.00456	CcSEcCtD
Prilocaine—Oedema—Dactinomycin—skin cancer	0.00365	0.00455	CcSEcCtD
Prilocaine—Dizziness—Imiquimod—skin cancer	0.00365	0.00454	CcSEcCtD
Prilocaine—Paraesthesia—Bleomycin—skin cancer	0.00352	0.00438	CcSEcCtD
Prilocaine—Vision blurred—Fluorouracil—skin cancer	0.00352	0.00438	CcSEcCtD
Prilocaine—Vomiting—Imiquimod—skin cancer	0.00351	0.00437	CcSEcCtD
Prilocaine—Hypertension—Temozolomide—skin cancer	0.0035	0.00436	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—SCN10A—skin cancer	0.00345	0.0212	CbGpPWpGaD
Prilocaine—Anaemia—Fluorouracil—skin cancer	0.00345	0.0043	CcSEcCtD
Prilocaine—Anxiety—Temozolomide—skin cancer	0.00343	0.00428	CcSEcCtD
Prilocaine—Neuropathy peripheral—Docetaxel—skin cancer	0.00338	0.00421	CcSEcCtD
Prilocaine—Pain—Bleomycin—skin cancer	0.00335	0.00417	CcSEcCtD
Prilocaine—Confusional state—Temozolomide—skin cancer	0.00333	0.00415	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—SCN10A—skin cancer	0.00332	0.0203	CbGpPWpGaD
Prilocaine—Anaphylactic shock—Temozolomide—skin cancer	0.0033	0.00412	CcSEcCtD
Prilocaine—Oedema—Temozolomide—skin cancer	0.0033	0.00412	CcSEcCtD
Prilocaine—Nausea—Imiquimod—skin cancer	0.00327	0.00408	CcSEcCtD
Prilocaine—Nervous system disorder—Temozolomide—skin cancer	0.00324	0.00404	CcSEcCtD
Prilocaine—Feeling abnormal—Bleomycin—skin cancer	0.00323	0.00402	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—SCN10A—skin cancer	0.0032	0.0196	CbGpPWpGaD
Prilocaine—Hyperhidrosis—Temozolomide—skin cancer	0.00319	0.00398	CcSEcCtD
Prilocaine—Pain—Dactinomycin—skin cancer	0.00312	0.00389	CcSEcCtD
Prilocaine—Urticaria—Bleomycin—skin cancer	0.00311	0.00388	CcSEcCtD
Prilocaine—Hypoaesthesia—Docetaxel—skin cancer	0.00308	0.00384	CcSEcCtD
Prilocaine—Confusional state—Fluorouracil—skin cancer	0.00307	0.00383	CcSEcCtD
Prilocaine—Oedema—Fluorouracil—skin cancer	0.00304	0.00379	CcSEcCtD
Prilocaine—Anaphylactic shock—Fluorouracil—skin cancer	0.00304	0.00379	CcSEcCtD
Prilocaine—Feeling abnormal—Dactinomycin—skin cancer	0.00301	0.00375	CcSEcCtD
Prilocaine—Nervous system disorder—Fluorouracil—skin cancer	0.00299	0.00372	CcSEcCtD
Prilocaine—Paraesthesia—Temozolomide—skin cancer	0.00297	0.0037	CcSEcCtD
Prilocaine—Somnolence—Temozolomide—skin cancer	0.00294	0.00366	CcSEcCtD
Prilocaine—Hypersensitivity—Bleomycin—skin cancer	0.00289	0.0036	CcSEcCtD
Prilocaine—Hypotension—Fluorouracil—skin cancer	0.00284	0.00355	CcSEcCtD
Prilocaine—Pain—Temozolomide—skin cancer	0.00283	0.00352	CcSEcCtD
Prilocaine—Asthenia—Bleomycin—skin cancer	0.00281	0.0035	CcSEcCtD
Prilocaine—Arrhythmia—Docetaxel—skin cancer	0.00276	0.00344	CcSEcCtD
Prilocaine—Paraesthesia—Fluorouracil—skin cancer	0.00273	0.00341	CcSEcCtD
Prilocaine—Feeling abnormal—Temozolomide—skin cancer	0.00272	0.00339	CcSEcCtD
Prilocaine—Somnolence—Fluorouracil—skin cancer	0.00271	0.00337	CcSEcCtD
Prilocaine—Hypersensitivity—Dactinomycin—skin cancer	0.00269	0.00335	CcSEcCtD
Prilocaine—Urticaria—Temozolomide—skin cancer	0.00262	0.00327	CcSEcCtD
Prilocaine—Asthenia—Dactinomycin—skin cancer	0.00262	0.00327	CcSEcCtD
Prilocaine—Pain—Fluorouracil—skin cancer	0.0026	0.00324	CcSEcCtD
Prilocaine—Feeling abnormal—Fluorouracil—skin cancer	0.00251	0.00313	CcSEcCtD
Prilocaine—Vomiting—Bleomycin—skin cancer	0.00249	0.0031	CcSEcCtD
Prilocaine—Anaemia—Docetaxel—skin cancer	0.00249	0.0031	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—SCN10A—skin cancer	0.00246	0.0151	CbGpPWpGaD
Prilocaine—Hypersensitivity—Temozolomide—skin cancer	0.00243	0.00303	CcSEcCtD
Prilocaine—Urticaria—Fluorouracil—skin cancer	0.00242	0.00301	CcSEcCtD
Prilocaine—Syncope—Docetaxel—skin cancer	0.00241	0.00301	CcSEcCtD
Prilocaine—Asthenia—Temozolomide—skin cancer	0.00237	0.00295	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—SCN10A—skin cancer	0.00237	0.0145	CbGpPWpGaD
Prilocaine—Loss of consciousness—Docetaxel—skin cancer	0.00237	0.00295	CcSEcCtD
Prilocaine—Nausea—Bleomycin—skin cancer	0.00233	0.0029	CcSEcCtD
Prilocaine—Hypertension—Docetaxel—skin cancer	0.00232	0.0029	CcSEcCtD
Prilocaine—Vomiting—Dactinomycin—skin cancer	0.00232	0.00289	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—SCN10A—skin cancer	0.00228	0.014	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—SCN10A—skin cancer	0.00225	0.0138	CbGpPWpGaD
Prilocaine—Hypersensitivity—Fluorouracil—skin cancer	0.00224	0.0028	CcSEcCtD
Prilocaine—Confusional state—Docetaxel—skin cancer	0.00222	0.00276	CcSEcCtD
Prilocaine—Anaphylactic shock—Docetaxel—skin cancer	0.0022	0.00274	CcSEcCtD
Prilocaine—Oedema—Docetaxel—skin cancer	0.0022	0.00274	CcSEcCtD
Prilocaine—Dizziness—Temozolomide—skin cancer	0.00218	0.00272	CcSEcCtD
Prilocaine—Nausea—Dactinomycin—skin cancer	0.00217	0.0027	CcSEcCtD
Prilocaine—Shock—Docetaxel—skin cancer	0.00216	0.00269	CcSEcCtD
Prilocaine—Nervous system disorder—Docetaxel—skin cancer	0.00215	0.00269	CcSEcCtD
Prilocaine—Vomiting—Temozolomide—skin cancer	0.0021	0.00262	CcSEcCtD
Prilocaine—Hypotension—Docetaxel—skin cancer	0.00205	0.00256	CcSEcCtD
Prilocaine—Dizziness—Fluorouracil—skin cancer	0.00201	0.00251	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—RASA1—skin cancer	0.00198	0.0121	CbGpPWpGaD
Prilocaine—Paraesthesia—Docetaxel—skin cancer	0.00197	0.00246	CcSEcCtD
Prilocaine—Nausea—Temozolomide—skin cancer	0.00196	0.00245	CcSEcCtD
Prilocaine—Somnolence—Docetaxel—skin cancer	0.00195	0.00243	CcSEcCtD
Prilocaine—Vomiting—Fluorouracil—skin cancer	0.00194	0.00241	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—RASA1—skin cancer	0.0019	0.0117	CbGpPWpGaD
Prilocaine—Pain—Docetaxel—skin cancer	0.00188	0.00234	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—RASA1—skin cancer	0.00184	0.0113	CbGpPWpGaD
Prilocaine—Feeling abnormal—Docetaxel—skin cancer	0.00181	0.00226	CcSEcCtD
Prilocaine—Nausea—Fluorouracil—skin cancer	0.00181	0.00225	CcSEcCtD
Prilocaine—Hypersensitivity—Docetaxel—skin cancer	0.00162	0.00202	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—SCN10A—skin cancer	0.0016	0.00983	CbGpPWpGaD
Prilocaine—Asthenia—Docetaxel—skin cancer	0.00158	0.00196	CcSEcCtD
Prilocaine—Dizziness—Docetaxel—skin cancer	0.00145	0.00181	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—RASA1—skin cancer	0.00141	0.00867	CbGpPWpGaD
Prilocaine—Vomiting—Docetaxel—skin cancer	0.0014	0.00174	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—RASA1—skin cancer	0.00136	0.00833	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—RASA1—skin cancer	0.00131	0.00803	CbGpPWpGaD
Prilocaine—Nausea—Docetaxel—skin cancer	0.00131	0.00163	CcSEcCtD
Prilocaine—SCN5A—Axon guidance—RASA1—skin cancer	0.00129	0.00791	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—RASA1—skin cancer	0.000921	0.00565	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—CDK4—skin cancer	0.000694	0.00425	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—CDK4—skin cancer	0.000667	0.00408	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—CDK4—skin cancer	0.000643	0.00394	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—NRAS—skin cancer	0.000541	0.00331	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—NRAS—skin cancer	0.000519	0.00318	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—NRAS—skin cancer	0.000501	0.00307	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—KRAS—skin cancer	0.000465	0.00285	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—CDK4—skin cancer	0.000452	0.00277	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—KRAS—skin cancer	0.000447	0.00274	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—IL6—skin cancer	0.000442	0.00271	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—KRAS—skin cancer	0.000431	0.00264	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—HRAS—skin cancer	0.000395	0.00242	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—NRAS—skin cancer	0.000386	0.00236	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—HRAS—skin cancer	0.00038	0.00233	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—IL6—skin cancer	0.000379	0.00232	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—NRAS—skin cancer	0.000371	0.00227	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—HRAS—skin cancer	0.000366	0.00225	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—IL6—skin cancer	0.000364	0.00223	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—NRAS—skin cancer	0.000357	0.00219	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—NRAS—skin cancer	0.000352	0.00216	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—IL6—skin cancer	0.000351	0.00215	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—KRAS—skin cancer	0.000332	0.00203	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—KRAS—skin cancer	0.000319	0.00195	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—KRAS—skin cancer	0.000308	0.00188	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—KRAS—skin cancer	0.000303	0.00186	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—HRAS—skin cancer	0.000282	0.00173	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—HRAS—skin cancer	0.000271	0.00166	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—IL6—skin cancer	0.00027	0.00166	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—HRAS—skin cancer	0.000261	0.0016	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—IL6—skin cancer	0.00026	0.00159	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—HRAS—skin cancer	0.000258	0.00158	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—NRAS—skin cancer	0.000251	0.00154	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—IL6—skin cancer	0.00025	0.00153	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—IL6—skin cancer	0.000247	0.00151	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—KRAS—skin cancer	0.000216	0.00133	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—HRAS—skin cancer	0.000184	0.00113	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—IL6—skin cancer	0.000176	0.00108	CbGpPWpGaD
